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Presidential address: Overcoming our fear of 
flying--Vascular surgery in the next decade 
Bruce L. Gewertz, MD, Chicago, Ill. 
Presidential addresses invariably begin with a 
statement acknowledging the difficulty of choosing a
suitable topic from the many compelling issues that 
face the profession. Although I certainly have been 
concerned that I not waste the time you have en- 
trusted to me, I can say that there has been no 
question in my mind as to the topic I wished to 
discuss: in this day and age, what can physicians and 
surgeons do to regain the sense of purpose and pride 
that motivated so many of us to choose the healing 
arts as a career? This question isparticularly relevant to 
practitioners of the specialty of  vascular surgery be- 
cause our field has always been imbued with a sense of 
excitement and innovation that reflect the special 
challenges of  the disorders we treat and the remark- 
able talents of those who blazed the trail. Indeed, 
many of these leaders it among us today as founding 
members of this organization. 
In discussions with many of our colleagues, I have 
been struck with the pervasiveness of  these feelings of 
discomfort and, in the extreme, despair for our profes- 
sional futures. In certain aspects, this reaction mirrors 
the irrational fear of flying--no matter how small the 
likelihood of a plane crash, a substantial number of 
Americans associate flying in commercial ircraft with 
"risk taking." This belief is remarkably resistant to the 
reality of the situation that is often expressed by the 
hackneyed statistical construct that one has a many 
times greater chance of dying in a car accident on the 
way to the airport han during the flight itself. 
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Fear of fying illustrates that as emotional beings 
we formulate responses on the basis of the "per- 
ceived" risk and not the "true" risk of an activity. The 
mechanism of this response has been well studied. 
Most psychologists believe that fear of flying is rooted 
in the loss of control experienced more acutely when 
traveling in an airplane than in an automobile. 
It is my hypothesis that the professional anxiety 
that many physicians feel today also reflects a per- 
ceived lack of control: in this instance, we fear not for 
our personal safety but for our practices and our 
futures. I hasten to add, however, that unlike airline 
passengers we physicians have considerable control of 
our destiny. Such control resides in our individual and 
collective behavior but can only be exercised if we first 
understand the true issues impacting our profession, 
above and beyond finances, and then address them 
honestly and forthrightly. Things may not be the same 
as in the mythical "old days," yet remarkable oppor- 
tunities remain to improve the welfare of our patients, 
to contribute to new knowledge, and to regain the 
leadership osition in health care that physicians have 
enjoyed and served so ably. 
Although it is my hope to suggest for your 
consideration some of these active and positive be- 
haviors, our discussion must begin with a overview of 
the current situation. I will briefly comment on the 
commercialization f health care, consider the attrac- 
tiveness of medicine as a "take-over target" for big 
business and, most importantly, focus on what we can 
do, beginning today, to recapture the initiative. 
There is little argument that economic onstraints 
are dramatically influencing the delivery of health care 
in our country. Perhaps the most surprising aspect of 
this change is how long it has been in coming. 
Virtually all industrialized nations in Europe and our 
neighbors to the north have placed considerable 
controls on overall spending for medical care. Al- 
though arguments may be raised as to whether these 
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policies adversely affect he overall quality of care and 
health, the access of patients to specific physicians i  
affected and, in some circumstances, impeded. Be- 
cause physicians in these systems often experience 
restricted practice opportunities, income levels have 
declined. 
With the failure of a federal legislative approach in 
1994, health care costs in our country are increasingly 
controlled or, in their parlance, "managed" by large 
insurance concerns. As noted by John Iglehart, 1 these 
entities are more and more motivated by profit rather 
than the sense of social mission that previously char- 
acterized the pioneers of prepaid plans such as Kaiser 
Permanente. This trend is indicated in the constitu- 
ency of the Group Health Association, which has 
evolved from having a majority of non-profit organi- 
zations in 1988 to having a majority of for-profir 
businesses in 1993. 
One of the most revealing insights into this 
evolving industry isthe newly minted term of"medi- 
cal loss," used to characterize allmoneys disbursed to 
physicians or hospitals to provide care. In most 
for-profit businesses, "medical loss" is strictly scruti- 
nized and limited to 80% of collected premiums, 
which allows a full 20% for administrative costs and 
profit. That the principle function of the organization, 
financing medical care, is considered a "loss" rather 
than a "product" demonstrates how far distant he 
mission of these insurance companies i  from that of 
the medical profession. 
Predictably, the commitment tostockholders and 
the bottom line has created conflicts with patients and 
providers. It is simply impossible to attend a social 
event with colleagues without hearing of daily tele- 
phone battles with insurance companies followed by 
egregious denials of care or payment to the detriment 
of both patient and doctor. Such discussions have a 
short-term cathartic effect but do little to solve the 
very real human problems that follow such constraints 
on care. Worse yet, I would respectfully suggest that 
they deflect our attention from the two related 
phenomena that have led most directly to the non- 
physician "management" of medicine: first, the sub- 
stantial differences in the use of surgical procedures 
and other medical services from one community to 
another; and second, the lack of success of our 
profession i  addressing these discrepancies. 
These large variations in practice patterns, which 
have been recognized since the mid-1970's, con- 
vinced outsiders that physician behavior eflected 
geographic peculiarities dictated by cultural factors 
and not clinical science. Putting it simply, business- 
men with regional or national perspectives saw an 
opportunity to profit by charging premiums on the 
basis of the prevailing usage rates and then enforcing 
the lowest usage rates. That the lowest rates are 
euphemistically termed "best practices" has failed to 
convince many of us of their uniform credibility. 
Nonetheless, if physicians are to regain influence over 
the allocation of health care, we must better under- 
stand the maldistribution f medical services and we 
must develop strategies to deal with it. 
A few examples may illustrate the magnitude of 
the problem. The epidemiologic technique of"small 
area analysis" pioneered by John Wennberg in the 
1970's has provided remarkable insights into the 
geographic variability of practice patterns. With this 
method, demographics of several defined populations 
are compared with respect o multiple economic, 
medical, and sociologic variables. One of the most 
consistent relationships in the many studies per- 
formed to date is that rates of hospitalization, stan- 
dardized per 1,000 patients, directly parallel the 
number of hospital beds available. Although the most 
simple explanation for these disparities might be 
differences in severity of illness or "case mix," many 
tightly controlled studies uggest otherwise. 
Fisher and colleagues 2 recently published a de- 
tailed study of the readmission rates of Medicare 
patients in Boston and New Haven who were initially 
treated for five serious medical and surgical diseases 
between 1987 and 1989. The medical demographics 
of the two communities were virtually identical. 
Teaching hospitals accounted for more than 85% of 
the admissions inboth areas, and the overall mortality 
rate for the cohorts were the same during the time 
interval. 
Despite these similarities, patients over 65 years of 
age who lived in Boston had a 64% higher incidence of 
readmission i  the next 3 years than did those in New 
Haven. Although some variation existed among hos- 
pitals, even the lowest readmission rate among the 
Boston-area hospitals was 50% greater than the mean 
readmission rate in New Haven. This general relation- 
ship held for all clinical indications. Readmissions for 
each successive 6-month interval were consistently 
higher in Boston whether the initial admission was for 
stroke, myocardial infarction, gastrointestinal bleed- 
ing, hip fracture, or cancer surgery. It may be of 
interest hat the causes for readmission were more 
commonly medical problems than surgical problems. 
The heterogeneity in physician management of
what might be considered medical "judgement calls" 
is also evident when considering the expenditures for 
physician services across the country. When Welch 
and colleagues 3 analyzed the Medicare payments o 
physicians in 317 metropolitan areas in 1989, they 
found that expenditures per patient varied markedly, 
with the highest areas more than twice as costly as the 
lowest. Surprisingly, the variations inexpenditures did 
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not reflect he cost of living--for example, San Fran- 
cisco's rate of $872 per patient per year was less than 
half of Miami's rate ($1874 per patient per year ) even 
though the cost of living in these two regions are quite 
comparable. 
Although no clinical measures of outcome, in- 
chiding overall mortality, were correlated with these 
differences, one strong relationship was demon- 
strated. The proportion of physicians engaged in 
primary care influenced admission rates and expendi- 
tures at every level, including inpatient and outpatient 
services. The fewer primary care physicians, the 
higher the costs. Considering these data, it is hardly a 
surprise that managed care organizations and health 
maintenance organizations (HMOs) are driving the 
physician supply toward primary care roles. In the 
typical multispecialty groups surveyed by Robert 
Dickler of the Association of American Medical Col- 
leges in 1993 (personal communication, Nov. 1993), 
the percentage of employed physicians who are spe- 
cialists (56%) was lower than the national average 
(64%), whereas the representation f primary care 
physicians was proportionately higher (44% in HMOs 
vs 36% national mean). 
Although the economic effects of the maldistri- 
bution of medical services are unsettling, other con- 
sequences ofthese variable usage rates pose even more 
difficult questions. These inequities are evident in 
many areas of practice, but for our purposes let us 
focus on cerebrovascular disease. Carotid endarterec- 
tomy has long been a favorite topic of investigation; 
medical specialists have taken issue with the indica- 
tions for surgery and decried uneven results and 
marginal ong-term benefits of the procedures. A
recent report by Gillum 4 attempted to determine 
whether the favorable outcomes of the randomized 
prospective trials reported in 1991 impacted the use 
of cerebral arteriography and endarterectomy. 
The rates of endarterectomy decreased precipi- 
tously in 1985, coinciding with a general ack of 
enthusiasm for surgical interventions ofany kind after 
publication of the negative xtracranial-intracranial 
bypass tudy. 5In 1991 the European carotid series in 
Lancet 6 and the North American Symptomatic Ca- 
rotid Endarterectomy Trial report in the New En- 
gland Journal Of Medicine 7 rekindled interest in the 
procedure, and the number ofendarterectomies again 
increased. Gillum was surprised to find, however, that 
the incidence of both procedures were much higher in 
the white population. White patients' rates ofangiog- 
raphy were roughly 30% higher than those of black 
patients, and rates ofendarterectomy in white patients 
were 4 to 5 times greater. Furthermore, changes in 
prevailing clinical opinion that led to modulations in
the number of procedures were virtually undetectable 
in the black population. Regardless of the literature, 
the use Of endarterectomy did not change in black 
Americans. It would be facile to explain these findings 
as another eflection of socioeconomic class or re- 
stricted access to care, but a number of other studies 
have not demonstrated any such relationship, s We 
should not be surprised that this problem has an 
uncertain cause and no easy remedy. At a minimum, 
however, the data should stimulate us, as the physi- 
cians most knowledgeable in the field, to devote more 
attention to understanding these issues. 
The obvious danger of such a discussion is now 
approaching. How can we address uch vast issues 
without ending up with half-vast solutions? After 
hopefully whetting your appetite for these problems, 
I must confess to harboring no illusions or "magic 
bullets." As individuals or collectively, we are unlikely 
to save the planet from a medical meltdown even if 
one were upon us. Nonetheless, it is possible for us to 
initiate a few well-chosen actions that can make a 
difference and reassure us that we can still influence 
the delivery of medical care. 
It is encouraging to note that our specialty has 
unique market advantages. We research, diagnose, 
and treat prevalent diseases that, if left untreated, have 
high morbidity; outcomes of treatment, including 
perioperative mortality and long-term graft patency, 
are measurable; our research as been productive; and 
the workforce is relatively small and the incoming 
supply restricted to the number of fellowships. Finally, 
as is the current mandate, we as specialists still perform 
a disproportionate amount of primary care. 
This organization has a real opportunity to capi- 
talize on these advantages. Our membership repre- 
sents the very best in community and academic 
practice and is well positioned to define what "best 
practices" really are in vascular surgery in our region. 
This effort will require a commitment by each of us to 
voluntarily track usage data such as admission rates, 
outpatient visits, length of stay, and perioperative risk, 
and to share these demographics freely with each 
other to identify strategies to safely lower costs and 
improve outcomes. Although such activities would 
undoubtedly represent a very different function for 
this organization, the power of this information, 
tracked longitudinally and collected throughout our 
membership, would be compelling. I would expect 
that substantial funding for this database could be 
garnered from a number of sources, including the 
managed care entities themselves. 
Led by professional societies uch as the Midwest 
Vascular Society, we must make a concerted effort in 
our postgraduate education programs to better un- 
derstand the physician's complex role in this "new 
world order" of health care. As recognized by Marcia 
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Angell, 9 modern physicians are now "double agents," 
asked like no other professional to balance the needs 
of their individual patients against he needs of the 
society as a whole. Evaluating the best use of resources 
requires a new set of skills and involves substantial 
ethical conflicts that we should attempt o unravel. 
Because analytic and management techniques were 
not taught formally within the surgical residencies of 
the past, they are not considered to be among our core 
competencies. I would respectfully submit that they 
need to be. It is by now quite evident. If  we do not 
involve ourselves in the process of  health care man- 
agement beyond the political horse-trading ofphysi- 
cian reimbursement schedules, these decisions will 
continue to be someone else's prerogative, to the 
detriment of  our patients and ourselves. 
Even more important than the initiatives of this or 
other societies are the personal actions we can each 
take to shape our destiny. First and foremost, we must 
never lose the ability to see our profession through 
our patients' eyes. This commitment to our patients 
begins with the quality of our surgical skills but 
extends to patients' experiences in our offices, to 
overheard conversations in the corridors, and to the 
ease or lack of ease with which we relate to them and 
their families. Always putting our patients first is the 
key to what will be a long but necessary political battle 
to reduce the unreasonable 20% to 30% administrative 
costs and profit margins of the for-profit health 
networks. This battle must be fought in our respective 
state and federal legislatures, but it will only be won if 
accompanied by a public conviction that physicians' 
motivation is improved medical care and not a better 
reimbursement rate. 
Finally, if wc see ourselves as knights in shining 
armor fighting our patients' battles against both 
disease and unfeeling insurance companies, we had 
best stop complaining about the injustices visited on 
us. In short, no one is comforted by a champion who 
spends his or her time whining. Our greatest weapon 
is the enviable track record of American medicine in 
improving both the length and quality of life of our 
citizens. The past 25 years have seen a reduction in the 
death rate from cardiovascular disease well in excess of 
the overall reduction in mortality, with even more 
dramatic decreases in mortality rates from coronary 
artery disease and stroke. 9These data arc remarkable 
and should provide us with considerable comfort 
regardless of  our current difficulties. Referencing the 
initial analogy to air travel, we must accept the 
turbulence of the flight without, as they say in the 
"friendly skies," too anxiously preparing for a "water 
landing" (an oxymoron if I've ever heard one). 
Our predecessors in surgery overcame challenges 
that we can only imagine. We practice in an era of 
technologic sophistication i which the level of un- 
derstanding of vascular disease is increasing at an 
unprecedented pace. The challenge for our genera- 
tion is to fine-tune the extraordinary engine that is 
American medicine, to mal~e it more responsive to the 
economic and social imperatives of our time. 
Despite the pressures of time and other commit- 
ments, we cannot allow this process to go forward 
without our input and, in particular, without the 
creativity and dedication you demonstrate daily in 
your practice of high-quality medicine. The remark- 
able achievements of our specialty over the past 30 
years provide the best evidence of our determination 
and the greatest testimony to our eventual success. 
The turbulence of the journey will not deter us from 
carrying forth in this same tradition. 
In closing, I thank you most sincerely for the 
honor of serving as your president this year. I am look- 
ing forward to learning from each of you in the 
future. 
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